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RESEARCH AND DEVELOPMENT ON DRUGS 
Drug development is the process of bringing a new pharmaceutical drug to the 
market once a lead substance has been identified through the process of drug 
discovery. Research in these areas generally comprises a combination of preclinical 
studies (in vitro studies, in vivo studies) and clinical trials. It takes about 12-15 years 
from the time of the detection of approved drugs and requires an investment of 
approximately $1 billion. [4] 
An NCE is a molecule developed by the innovator company in the early drug 
discovery stage, which after undergoing clinical trials will turn into a drug that will a 
treatment for definite disease.  
Nowadays drug development is dominated by small-molecule new chemical 
entities traditionally distinguished from macromolecular agents regarded as 
biologicals. 
Synthesis of an NCE is the first step in the process of drug development. It is 
long important process. It can take decades to develop a new molecule. [3] 
Next step is testing. Drug development is required to establish the 
physicochemical properties of the NCE. The process by which the chemical is made 
will be optimized so that from being made at the bench on a milligram scale by a 
synthetic chemist, it can be manufactured on the kilogram and then on the ton scale. 
It will be further examined for its suitability to be made into certain dosage form: 
aerosol, tablets, capsules, intravenous formulations. subcutaneous or intramuscular 
injectable. Most NCEs can will fail during drug development, either because they 
have some unacceptable toxicity. 
Before starting any clinical trial, researchers must submit an application (IND) 
to investigate new drugs in the FDA. The application must contain the results of 
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preclinical studies, the chemical structure of the candidates for medicine, a 
description of their biological effects, a list of side effects, etc. In addition, the 
application includes a detailed plan of clinical trials, information about their venue 
and participants.  
Clinical trials consist of three phases: 
1. Initial clinical trials in a small group of healthy volunteers (from 20 to 100 
people). 
The main task of this test Phase is to find out how safe the preparation is for 
humans. Scientists study pharmacokinetics (chemical transformation of drugs in the 
body) and pharmacodynamics (mechanisms of action of drugs on the body) of the 
drug, find out whether the drug gives the desired effect, or there are no side effects. 
All studies are carefully scrutinized by scientists to determine the range of safe 
concentrations of the drug for humans and the transition to the next stage. [2] 
2. Testing on a small group of patients (from 100 to 500 people). 
During Phase 2 trials, scientists are studying short-term side effects and risks 
associated with drug use. They also try to answer the question ―Does the drug work 
according to the expected mechanism?‖ and ―Does it improve the condition of the 
patients?‖. Active doses and drug use patterns are being developed. If it shows itself 
well scientists are preparing for the next longer phase of clinical trials. [2] 
3. Drug testing in a large group of patients to show the safety of drugs and their 
efficacy (about 1000-5000 people). 
Researchers are studying the drug in a large group of patients in order to obtain 
complete statistics on the safety of the drug, its efficacy and the ratio of the resulting 
therapeutic effect and possible risks. This phase of the study is key to determining 
whether a drug is safe and effective. It also provides the basis for developing 
instructions for use of the drug. Phase 3 is the most expensive, and the longest of all 
studies. Tests are conducted simultaneously in different countries, in many groups of 
people. During this stage, full-scale production plans are being developed and a very 
complicated FDA application is being prepared for drug registration. [1] 
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The study of new drugs continues even after their approval. As far as more 
patients start using new medications, manufacturing companies are required to 
monitor the medication and periodically report to the FDA. Sometimes the FDA for 
the determination of long-term drug safety requires companies to conduct additional 
studies in the so-called Phase 4 trials. 
Hence, the development of medicines is a long and complex process aimed at 
improving people's lives. Any new substance is subject to rigorous testing to reduce 
the risk to human health and achieve the maximum effectiveness of the new drug. 
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